CE Certified Blood CFDNA BCT for Molecular Diagnostic

CE Certified Blood CFDNA BCT for Molecular Diagnostic

Company info

BunnyTeeth Technology Inc. is committed to building a complete core technology platform for bioengineering, building a high-quality biotech product chain and a technical service chain, with the ambition to become a global leader in molecular and genetic diagnostic. BunnyTeeth Technology Inc. will also provide customers with a full-range of one-step service solution in the field of molecular diagnostics and genetic diagnostic.

Product abstract

Product description:

The role of plasma cell-free DNA (cfDNA) is becoming increasingly evident as an important test sample for tumor diagnosis and non-invasive prenatal screening. CE Certified Blood CFDNA BCT for Molecular Diagnostic can be directly used for whole blood collection, preservation and transportation, which can effectively protect cfDNA from degradation by nucleases and avoid the release of genomic DNA from blood nucleated cells, greatly ensuring the downstream application of cfDNA.

Advantage

1. Technique:Use EDTA-K3 as anticoagulant, which has highest solubility in the liquid, to bind to Ca²⁺ ions in blood to form chelates, and inhibit thrombospondin activation to prevent blood clotting.
2. Production:Full set of reagents are manufactured in GMP production factory with ISO13485 standard; control the source production process, use scientific verification system with industry gold standard
3. Application:Thousands of clinical samples tested in the NGS testing laboratory of Geneseeq (CAP & CLIA certified), with stable results and expected performance indicators.

Figure 1. Excellent quality control data for NGS.

The quality control of cfDNA extracted from blood samples preserved in CE Certified Blood CFDNA BCT for Molecular Diagnostic into the NGS process by our kits is excellent and shows high consistency with Streck preservation tubes.

Component

Storage condition

Storage Temperature: 10- 30 ℃

Shelf life: 12 months

Applied Scene

1. Fetal non-invasive birth defect screening (non-invasive Down's syndrome test)
2. Tumor biomarker discovery and research
3. Oncology treatment and efficacy assessment studies
4. Clinical drug development and testing
5. Related disease molecular level research